Remdesivir and GS-441524

被引：0
|
作者：
Yan, Victoria
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2021年 / 99卷 / 23期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Practical and Highly Efficient Synthesis of Remdesivir from GS-441524
    Hu, Tianwen
    Zhu, Fuqiang
    Xiang, Li
    Shen, Jingshan
    Xie, Yuanchao
    Aisa, Haji A.
    ACS OMEGA, 2022, 7 (31): : 27516 - 27522
  • [2] NEW AND PRACTICAL SYNTHESIS OF GS-441524, THE KEY INTERMEDIATE OF REMDESIVIR
    Li, Bo
    Wang, Han
    Sun, Cong
    Lu, Sheng
    Kang, LinLin
    Jiang, Shun
    HETEROCYCLES, 2021, 102 (09) : 1797 - 1802
  • [3] Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study
    Louchet, Margaux
    Ribot, Megane
    Bouazza, Naim
    Foissac, Frantz
    Froelicher, Leo
    Buth, Victoria
    Benaboud, Sihem
    Treluyer, Jean-Marc
    Lui, Gabrielle
    HEALTH SCIENCE REPORTS, 2023, 6 (07)
  • [4] An efficient synthesis of RNA containing GS-441524: the nucleoside precursor of remdesivir
    Moorthy, Ramkumar
    Kennelly, Samantha A.
    Rodriguez, Deborah J.
    Harki, Daniel A.
    RSC ADVANCES, 2021, 11 (50) : 31373 - 31376
  • [5] Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy
    Schmidt, Julius J.
    Bode-Boeger, Stefanie M.
    Martens-Lobenhoffer, Jens
    Hoeper, Marius M.
    Kielstein, Jan T.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08): : 1256 - 1257
  • [6] Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity
    Yan, Victoria C.
    Muller, Florian L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
  • [7] Remdesivir and GS-441524 Extraction by Ex Vivo Extracorporeal Life Support Circuits
    Imburgia, Carina E.
    Rower, Joseph E.
    Green, Danielle J.
    Mcknite, Autumn M.
    Kelley, Walter E.
    Reilly, Christopher A.
    Watt, Kevin M.
    ASAIO JOURNAL, 2022, 68 (09) : 1204 - 1210
  • [8] Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
    Leegwater, E.
    Moes, D. J. A. R.
    Bosma, L. B. E.
    Ottens, T. H.
    van der Meer, I. M.
    van Nieuwkoop, C.
    Wilms, E. B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [9] Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
    Amirian, E. Susan
    Levy, Julie K.
    ONE HEALTH, 2020, 9
  • [10] Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
    Yan, Victoria C.
    Muller, Florian L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (07): : 1361 - 1366
12345